Ad is loading...
ECIFX
Price
$12.32
Change
-$0.17 (-1.36%)
Updated
Nov 15 closing price
RAMHX
Price
$35.93
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

ECIFX vs RAMHX

Header iconECIFX vs RAMHX Comparison
Open Charts ECIFX vs RAMHXBanner chart's image
Eaton Vance Balanced C
Price$12.32
Change-$0.17 (-1.36%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R2E
Price$35.93
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
ECIFX vs RAMHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ECIFX vs. RAMHX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ECIFX is a StrongSell and RAMHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RAMHX has more cash in the bank: 236B vs. ECIFX (988M). RAMHX pays higher dividends than ECIFX: RAMHX (1.84) vs ECIFX (0.65). ECIFX was incepted earlier than RAMHX: ECIFX (31 years) vs RAMHX (10 years). RAMHX is a more actively managed with annual turnover of: 171.00 vs. ECIFX (2.00). RAMHX has a lower initial minimum investment than ECIFX: RAMHX (250) vs ECIFX (1000). ECIFX annual gain was more profitable for investors over the last year : 23.13 vs. RAMHX (20.31). RAMHX return over 5 years is better than : 32.43 vs. ECIFX (27.28).
ECIFXRAMHXECIFX / RAMHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years10 years-
Gain YTD17.83513.582131%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets988M236B0%
Annual Yield % from dividends0.651.8435%
Returns for 1 year23.1320.31114%
Returns for 3 years1.809.3919%
Returns for 5 years27.2832.4384%
Returns for 10 years41.9846.7490%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRVL344.74-1.93
-0.56%
CorVel Corp
FLUT265.45-1.55
-0.58%
Flutter Entertainment plc
INVA18.90-0.34
-1.77%
Innoviva
CMMB1.67-0.06
-3.74%
Chemomab Therapeutics Ltd
MVST0.72-0.06
-7.68%
Microvast Holdings